title: Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
authors.affiliation: 1st Dept of Medical Oncology, St. Savas Hosp. Athens, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Papacharalambous
authors.forename: G
authors.initials: G
authors.lastname: Rigatos
authors.forename: A
authors.initials: A
authors.lastname: Alexopoulos
authors.forename: J
authors.initials: J
authors.lastname: Stavrakakis
authors.forename: C
authors.initials: C
authors.lastname: Scartsilas
authors.forename: E
authors.initials: E
authors.lastname: Stavrinidis
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D008875:Middle Aged; D009367:Neoplasm Staging; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin